USE OF 3- (2-CHLORO-PHENYL) -1- 4- (4-FLUORO-BENZYL) -PIPERAZIN-1-YL -PROPENONE FOR THE PREVENTION AND / OR TREATMENT OF PELVI-PERINEAL FUNCTIONAL PATHOLOGIES

摘要

The present invention relates to the use of PAR1 antagonists, in particular of vorapaxar, of atopaxar and of 3-(2-chlorophenyl)-1-[4-(4-fluorobenzyl)piperazin-1-yl]propenone, or a pharmaceutically acceptable salt thereof, for preventing and/or treating pelvi-perineal functional pathological conditions, and more particularly painful bladder syndrome.